The Role of the Thioredoxin and Glutaredoxin Pathways in Reducing Protein Disulfide Bonds in the Escherichia coli Cytoplasm*

(Received for publication, January 31, 1997, and in revised form, April 12, 1997)

William A. Prinz , Fredrik Åslund Dagger , Arne Holmgren Dagger and Jon Beckwith §

From the Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115 and the Dagger  Medical Nobel Institute for Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institute, S-171 77 Stockholm, Sweden

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

In Escherichia coli, two pathways use NADPH to reduce disulfide bonds that form in some cytoplasmic enzymes during catalysis: the thioredoxin system, which consists of thioredoxin reductase and thioredoxin, and the glutaredoxin system, composed of glutathione reductase, glutathione, and three glutaredoxins. These systems may also reduce disulfide bonds which form spontaneously in cytoplasmic proteins when E. coli is grown aerobically. We have investigated the role of both systems in determining the thiol-disulfide balance in the cytoplasm by determining the ability of protein disulfide bonds to form in mutants missing components of these systems. We find that both the thioredoxin and glutaredoxin systems contribute to reducing disulfide bonds in cytoplasmic proteins. In addition, these systems can partially substitute for each other in vivo since double mutants missing parts of both systems generally allow substantially more disulfide bond formation than mutants missing components of just one system. Some of these double mutants were found to require the addition of a disulfide reductant to the medium to grow well aerobically. Thus, E. coli requires either a functional thioredoxin or glutaredoxin system to reduce disulfide bonds which appear after each catalytic cycle in the essential enzyme ribonucleotide reductase and perhaps to reduce non-native disulfide bonds in cytoplasmic proteins. Our results suggest the existence of a novel thioredoxin in E. coli.


INTRODUCTION

Disulfide bridges play an important structural role in many proteins (1, 2). While these bonds often occur in extracytoplasmic proteins, they are rarely found in cytoplasmic proteins (3, 4). It has been suggested that the cytoplasm is too reducing for many disulfide bonds to form (5, 6). In fact, when many exported proteins that ordinarily form disulfide bonds are expressed in the cytoplasm, they do not form these bonds (7, 8) (for an exception, see Ref. 9).

A number of factors are thought to determine the thiol-disulfide balance in the cytoplasm of Escherichia coli. The principle thiol-disulfide redox buffer in the cytoplasm is constituted by the cysteine containing tripeptide glutathione. E. coli contains high levels of glutathione (the intracellular concentration is approximately 5 mM) that is kept almost entirely reduced (10). The ratio of reduced to oxidized glutathione in the E. coli cytoplasm is roughly 50:1 to 200:1 (11). In vitro, similar levels of oxidized and reduced glutathione are not conducive to disulfide bond formation in many proteins (11-14).

In addition to glutathione, the E. coli cytoplasm contains at least four thiol-disulfide oxidoreductases that may help reduce protein disulfide bonds in the cytoplasm via their redox active disulfides: thioredoxin, glutaredoxin 1, glutaredoxin 2, and glutaredoxin 3 (15-17). Thioredoxin is the best characterized of these and belongs to a superfamily of proteins that contain an active site CX1X2C motif and share a similar fold, in those cases where structure is known (18). The redox potential of thioredoxin is low (-270 mV) (19) and, in vitro, thioredoxin efficiently reduces disulfide bonds in a wide variety of proteins (15, 20). Although they have not been as extensively tested as thioredoxin, the glutaredoxins are generally less efficient reductants of disulfide bonds than thioredoxin (16, 21). This may be partially explained by the higher redox potentials of the glutaredoxins (glutaredoxin 1 = -233 mV; glutaredoxin 3 = -198 mV).1

Upon reducing disulfide bonds, the thiol-disulfide oxidoreductases become oxidized. In order for these proteins to be functional, they in turn must be kept reduced. The flavoenzyme thioredoxin reductase uses NADPH to reduce thioredoxin but is unable to reduce any of the glutaredoxins (16, 22).2 Instead, the glutaredoxins are reduced by glutathione, which in turn is reduced by glutathione reductase. Like thioredoxin reductase, glutathione reductase is a flavoenzyme that uses NADPH to reduce its substrate. Since glutathione does not efficiently reduce thioredoxin (22) and the glutaredoxins are not substrates of thioredoxin reductase, it has been presumed that E. coli has two separate pathways for using NADPH to reduce disulfide bonds in the cytoplasm: the thioredoxin system (which consists of thioredoxin reductase and thioredoxin) and the glutaredoxin system (glutathione reductase, glutathione, and the three glutaredoxins) (Fig. 1) (16, 23).


Fig. 1. Known components of the thioredoxin system (top) and glutaredoxin system (bottom). The genes encoding the components of these systems are shown in parentheses.
[View Larger Version of this Image (20K GIF file)]

Similar systems are thought to reduce protein disulfide bonds in the cytoplasm of eukaryotic cells as well. Most eukaryotic cells contain high levels of reduced glutathione as well as thioredoxin and glutaredoxin (6, 15, 24, 25).

In E. coli, the thioredoxin and glutaredoxin systems are known to participate in the reduction of disulfide bonds in essential cytoplasmic enzymes which require this step to complete their catalytic cycles. These include ribonucleotide reductase, PAPS3 reductase, and methionine sulfoxide reductase (16). However, the ability of the thioredoxin and glutaredoxin systems to function in vivo as general reductants of cytoplasmic protein disulfide bonds has not been fully determined. We have previously demonstrated that the thioredoxin system has a role in this process (26). In this study, we have investigated the role of the glutaredoxin system and both systems together in determining the thiol-disulfide equilibrium in the cytoplasm.


EXPERIMENTAL PROCEDURES

Materials

Media and chemical reagents were prepared or purchased as described previously (27). Diazenedicarboxylic acid bis(N,N'-dimethylamide) (diamide) and DTT were purchased from Sigma.

Strains and Plasmids

The strains and plasmids used in this study are listed in Table I. Strains were constructed by P1 transduction (28). The mutant alleles of the genes encoding components of the thioredoxin and glutaredoxin systems (Fig. 1) used to construct the strains for this study are: trxB::Km (29), Delta trxA (30), gor522 (lab collection), gshA20::Tn10Km (31), grxA::Km (32), and grxC::Cm (this study). Three of the mutants (WP861, WP863, and WP864) contain trxB36 (26) in place of trxB::Km.

Table I. Strains and plasmids used in this work


Plasmids Description Source or reference

pDelta A-uPA  Delta A-uPA under control of tac promoter D. Belin
pAID135 APDelta 2-22 under control of tac promoter 27
pGrxC pGEM-3Z containing a 1723-bp fragment of the E. coli chromosome which includes grxC F. Åslund
pGrxC::Cm
pGrxC but with grxC::Cm
This work
Strains
Relevant genotype
Source or reference
DHB4 F' lac-pro lacIQ/Delta (ara-leu)7697 araD139 Delta lacX74 galE galK rpsL phoR Delta (phoA)PvuII Delta malF3 thi Lab collection
WP551 DHB4 + pAID135 This work
WP591 WP551 Delta trxA This work
WP552 WP551 trxB::Km This work
WP838 WP551 grxA::Km This work
WP823 WP551 grxC::Cm This work
WP776 WP551 gshA20::Tn10Km This work
WP841 WP551 gor522... . mini-Tn10Tc This work
WP898 WP551 gshA20::Tn10Km Delta trxA This work
WP786 WP551 gshA20::Tn10Km trxB::Km... . Tn10 This work
WP843 WP551 gor522... . mini-Tn10Tc Delta trxA This work
WP782 WP551 gor522... . mini-Tn10Tc trxB::Km This work
WP861 WP551 trxB36 grxA::Km This work
WP824 WP551 trxB::Km grxC::Cm This work
WP592 WP551 trxB::Km Delta trxA This work
WP863 WP551 trxB36 grxA::Km grxC::Cm This work
WP826 WP551 trxB::Km grxC::Cm Delta trxA This work
WP864 WP551 trxB36 grxA::Km grxC::Cm Delta trxA This work
WP839 WP551 Delta trxA grxA::Km This work
WP825 WP551 Delta trxA grxC::Cm This work
WP860 WP551 Delta trxA grxA::Km grxC::Cm This work
WP859 WP551 grxA::Km grxC::Cm This work
WP759 DHB4 gshA20::Tn10Km trxB::Km... . Tn10 This work
WP778 DHB4 gor522... . mini-Tn10Tc trxB::Km This work
WP613 DHB4 trxB36 Delta 1fbp... . Tn10Km Lab collection
AD494 DHB4 trxB::Km This work
WP840 DHB4 gor522... . mini-Tn10Tc This work
WP822 DHB4 Delta trxA grxA::Km grxC::Cm This work
WP758 DHB4 gshA20::Km This work
WP843 DHB4 Delta trxA gor522... . mini-Tn10Tc This work
WP612 DHB4 Delta trxA gshA20::Km This work
JCB495 recD J. Bardwell
WP522 DHB4 gor522... . mini-Tn10Tc Lab collection
JTG10 gshA20::Tn10Km 31
A304 trxB::Km 29
A307 Delta trxA 30
A407 grxA::Km 32
A305 trxB::Km... . Tn10 M. Russel

A strain in which the coding region of grxC, which encodes glutaredoxin 3, was replaced with a gene encoding chloramphenicol resistance (grxC::Cm) was constructed by linear transformation (33). For this purpose, we constructed a plasmid pGrxC::Cm, which contains grxC::Cm and the chromosomal DNA flanking grxC. We made pGrxC::Cm from pGrxC, which contains a 1723-base pair fragment of chromosomal DNA that includes grxC cloned into the EcoRI site of pGEM-3Z.4 pGrxC was cut with BalI and BamHI, which removes all but 20 base pairs of the coding sequence of grxC. A BamHI linker was added to the BalI site and the ends of the resulting fragment were ligated together. Into the BamHI site of the resulting plasmid, we cloned DNA encoding chloramphenicol resistance obtained from pHP45Omega -Cm (34) after digestion with BamHI. The resulting plasmid is called pGrxC::Cm. The fragment of chromosomal DNA containing grxC::Cm obtained from pGrxC::Cm after digestion with EcoRI was then used to transform JCB495 (recD) to chloramphenicol resistance. The replacement of grxC by grxC::Cm in the resulting strain was confirmed by P1 transduction, polymerase chain reaction, and Western blot analysis using anti-glutaredoxin 3 antibody (data not shown).

Construction and Growth of WP759 and WP778

Two of the strains constructed for this study, WP759 (trxB gshA) and WP778 (trxB gor), grew very poorly unless they were grown in medium that contains a disulfide reductant like DTT. To construct WP759, WP758 (gshA) was transduced with P1 grown on A305 (trxB::Km... . Tn10) and plated on NZ-amine-A plates containing 20 µg/ml tetracycline. A 1-cm filter disk containing 25 µl of 1 M DTT was placed on the plate. After incubated for 24 h at 37 °C, two types of colonies were observed: large colonies evenly distributed on the plate and small colonies that were only present roughly 1 to 2 cm from the filter disk. The large colonies did not require DTT for growth and were found by P1 transduction not to contain trxB::Km. The small colonies required DTT for growth and contained trxB::Km (by P1 transduction). The same procedure was used to construct WP778 except that AD494 (trxB::Km) was transducted to tetracycline resistance with P1 grown on WP522 (gor522... . mini-Tn10Tc).

WP759 and WP778 were grown on NZ-amine-A plates with 8 mM DTT. 4 and 2 mM DTT was used to grow these strains in liquid NZ-amine-A and liquid M63 minimal medium, respectively. In minimal medium, these strains require supplementation with cysteine.

Growth rates of WP759 and WP778 (Fig. 2) were determined as follows. Overnight cultures of both strains and DHB4 were grown at 37 °C in NZ-amine-A medium supplemented with 4 mM DTT. The cultures were diluted 1:100 in the same medium and their growth followed for 3 h by determining their optical density at 600 nm. The cells were then pelleted and resuspended in NZ-amide-A medium without DTT and their growth was followed for another 3 h. Growth rates were calculated from the average of three determinations and differed from one another by less than 1%.


Fig. 2. WP759 (trxB gshA) and WP778 (trxB gor) grow poorly without DTT. The growth rate of DHB4 (wild-type, open circle ), WP759 (trxB gor, triangle ), and WP778 (trxB gshA, square ) was followed by determining the optical density (at 600 nm) of cells grown in NZ-amine-A medium. A, cultures were grown for 3 h with 4 mM DTT. B, these cultures were pelleted, resuspended in media without DTT, and grown for 3 h.
[View Larger Version of this Image (12K GIF file)]

WP759 and WP778 accumulate suppressing mutations that allow them to grow about as rapidly as DHB4 (wild-type) in media that does not contain a disulfide reductant. Since these mutations arise at a high frequency (approximately 10-6 or 10-7), it was necessary to monitor the growth rate of these strains when they were grown without DTT (e.g. to determine AP activity or urokinase activity) to make sure that they grew slowly. Cultures that did not grow as slowly as those shown in Fig. 2B were discarded.

Alkaline Phosphatase Assays

The strains shown in Table II were grown at 37 °C in M63 minimal medium containing 0.2% glucose, 50 µg/ml each of all amino acids except methionine, 200 µg/ml ampicillin, and 5 mM isopropyl-1-thio-beta -D-galactopyranoside to a final optical density at 600 nm of approximately 0.4. They were then incubated on ice for 20 min in the presence of 100 mM iodoacetamide. The remainder of the assay was performed as described in Ref. 27, except that 100 mM iodoacetamide was used instead of 1 mM iodoacetamide in the wash buffer. The assays were performed in duplicate and varied by less than 5%.

Table II. AP activity of various strains expressing APDelta 2-22

Strains were grown in M63 minimal medium containing 0.2% glucose, 200 µg/ml ampicillin, 5 mM isopropyl-thio-beta -D-galactopyranoside, and 50 µg/ml each of all amino acids except methionine.

Strain Relevant genotype AP activity

WP551 Wild-type 90
WP552 trxB 870
WP591 trxA 130
WP841 gor 260
WP776 gshA 130
WP838 grxA 80
WP823 grxC 290
WP592 trxB trxA 310
WP861 trxB grxA 420
WP824 trxB grxC 860
WP843 trxA gor 860
WP898 trxA gshA 760
WP839 trxA grxA 63
WP825 trxA grxC 32
WP863 trxB trxA grxA 230
WP826 trxB trxA grxC 140
WP860 trxA grxA grxC 200
WP864 trxB trxA grxA grxC 290

The strains shown in Table III were grown at 37 °C to an optical density at 600 nm of approximately 0.6 in NZ-amine-A containing 200 µg/ml ampicillin and 4 mM DTT. They were pelleted, resuspended in NZ-amine-A containing 200 µg/ml ampicillin and 5 mM isopropyl-1-thio-beta -D-galactopyranoside, and grown at 37 °C for 3 h. The AP assays were then performed as above.

Table III. AP activity of strains expressing APDelta 2-22 after growth for 3 h without DTT

Strains were grown as described under "Experimental Procedures"

Strain Relevant genotype AP activity

WP551 Wild-type 38
WP552 trxB 240
WP782 trxB gor 1200
WP786 trxB gshA 1700

Zymography of Urokinase

Cells were grown in NZ-amine-A plus 200 µg/ml ampicillin and 4 mM DTT at 37 °C to an optical density at 600 nm of approximately 0.6. They were pelleted and resuspended in NZ-amine-A plus 200 µg/ml ampicillin and 5 mM isopropyl-1-thio-beta -D-galactopyranoside and grown for 3 h at 37 °C. Zymography using casein plasminogen agar underlays was performed as described previously (26) except that after incubation of the samples on ice for the times indicated in Fig. 3, iodoacetamide was added to 100 mM and the samples were incubated for an additional 20 min on ice.


Fig. 3. Urokinase becomes active in the cytoplasm of WP759 and WP778. Zymography with casein plasminogen underlays was performed as described under "Experimental Procedures." Protein extracts from the same numbers of cells were run in each lane. The numbers above the lanes indicate the amount of time the cells were held on ice before the addition of iodoacetamide.
[View Larger Version of this Image (62K GIF file)]

Treatment of Cells with Diamide

To determine the affect of diazenedicarboxylic acid bis(N,N'-dimethylamide) (diamide) on growth rate, cells were grown to an optical density of 0.2 at 600 nm in NZ-amine-A medium at 37 °C and diamide was then added to a final concentration of 250 mM. The growth of the cells was then followed by determining their optical density at 600 nm.


RESULTS

To investigate the role of the thioredoxin and glutaredoxin systems in maintaining the thiol-disulfide balance in the cytoplasm, we constructed a set of mutants missing various components of these systems. We then assessed the ability of disulfide bonds to form in the cytoplasm of these strains by determining the extent to which E. coli alkaline phosphatase (AP) is able to form disulfide bonds in the cytoplasm of the mutants. AP is a periplasmic homodimeric enzyme that contains two intrachain disulfide bonds in each monomer (35). These bonds are required for AP to be enzymatically active. AP is synthesized with an N-terminal signal sequence which targets it for export to the periplasm. When AP is expressed with a defective or missing signal sequence, it is not exported to the periplasm, but remains in the cytoplasm (36). In this compartment, AP does not form disulfide bonds and cannot fold into an enzymatically active conformation (8). However, in the cytoplasm of E. coli mutants missing thioredoxin reductase a fraction of a signal sequenceless version of AP (APDelta 2-22) does forms disulfide bonds and folds into an active conformation (26). Thus, APDelta 2-22 can be used to assess the potential for disulfide bond formation in the cytoplasm of the mutants missing components of the thioredoxin and glutaredoxin systems.

Construction of Mutants Lacking Components of the Thioredoxin and Glutaredoxin Systems

Some mutants lacking components of the thioredoxin and glutaredoxin systems have been previously constructed. However, these mutants are in different genetic backgrounds. To facilitate comparisons between the mutants, a set of isogenic strains was constructed by P1 transduction (Table I). The mutant alleles of each gene used in the construction of these strains do not make any detectable functional product of that gene (Refs. 29, 31, and 37; data not shown).

In addition to the previously described mutants lacking glutaredoxin 1 (encoded by grxA), we wished to obtain mutants lacking either glutaredoxin 2 or glutaredoxin 3. A mutant missing glutaredoxin 2 has only recently been constructed,5 and was not used in these studies.

We constructed a strain missing glutaredoxin 3 using linear transformation (33). The plasmid pGrxC contains a fragment of chromosomal DNA that includes grxC (which encodes glutaredoxin 3). The coding region of grxC in this plasmid was removed and replaced with DNA from pHP45Omega -Cm (34) which confers chloramphenicol resistance. The fragment of chromosomal DNA was then removed from the resulting plasmid and used to transform a recD strain (JCB495) to chloramphenicol resistance. The replacement of grxC with grxC::Cm was confirmed by polymerase chain reaction and P1 transduction (data not shown). Western blot analysis revealed that grxC::Cm cells contained no detectable glutaredoxin 3 (data not shown). grxC is in an operon with secB, which encodes an export-specific cytoplasmic chaperone. Western blots revealed that strains containing grxC::Cm did not make detectable amounts of SecB (data not shown).

Growth Requirements of the Mutants

Seven mutants constructed for this study could not grow in M9 or M63 minimal medium unless it was supplemented with cysteine or glutathione: WP839 (trxA grxA), WP860 (trxA grxA grxC), WP864 (trxB trxA grxA grxC), WP843 (trxA gor), WP898 (trxA gshA), WP824 (trxB grxA), and WP863 (trxB grxA grxC) (data not shown). DHB4, the wild-type parent of these strains, does not require these supplements. However, these additives were not required if the M9 medium was prepared with sulfite instead of sulfate (data not shown). None of these strains required cysteine or glutathione to grow in NZ-amine-A medium. Similar findings have been reported for trxB grxA and trxA grxA mutants and were attributed to the inability of these strains to reduce PAPS reductase, an enzyme that is required for growth when sulfate is the only source of sulfur in the medium (32, 38, 39).

E. coli Requires Either a Functional Thioredoxin or Glutaredoxin System to Grow Well Aerobically but Not Anaerobically

Two strains constructed for this study, WP759 (trxB gshA) and WP778 (trxB gor), grew extremely poorly. They formed microscopic colonies on rich medium (NZ-amine-A) after incubation for 1 day and small colonies after 4 days at 37 °C (wild-type cells form large colonies in 1 day). Since we suspected that these strains grew poorly because they were not able to efficiently reduce cytoplasmic protein disulfide bonds, we determined whether their growth rate could be improved by adding a disulfide reductant to the medium. Both strains grew at about the same rate as wild-type cells when 4 mM DTT was added to the medium (Fig. 2). The doubling time of WP759 and WP778 in NZ-amine-A medium without DTT is about 300 min, while this rate increases to 30 min when 4 mM DTT is added to the medium. The growth defect of these mutants could also be complemented by the addition of beta -mercaptoethanol, but not oxidized DTT, to the medium (data not shown). Interestingly, WP759 and WP778 were able to grow about as rapidly as wild-type cells, even in medium that did not contain DTT or another disulfide reductant, when the cells were grown anaerobically (data not shown).

Mutations that allow WP759 and WP778 to grow well aerobically without a disulfide reductant in the medium arose at a relatively high frequency (approximately 10-6 or 10-7). These mutations have not been characterized further.

Disulfide Bond Formation in the Cytoplasm of the Mutant Strains

APDelta 2-22 becomes active in the cytoplasm of the mutants missing components of either the thioredoxin or the glutaredoxin systems (Table II). We confirmed that the AP activity in some of these mutants in fact reflects an increase in the extent of disulfide bond formation in APDelta 2-22 by using the finding that oxidized and reduced APDelta 2-22 can be separated with nonreducing SDS-PAGE (8) to determine the redox status of APDelta 2-22 in the mutants (data not shown). As previously reported, mutants missing thioredoxin reductase allow a substantial amount of APDelta 2-22 (approximately 25%) to form disulfide bonds in the cytoplasm. Cells missing thioredoxin or one of the components of the glutaredoxin system allow less APDelta 2-22 to form disulfide bonds. The amount of AP activity in many of these mutants is only slightly higher than that found in wild-type cells. However, even these small differences probably indicate a substantial increase in the ability of APDelta 2-22 to form disulfide bonds in the cytoplasm of these mutants. We suggest this since, as far as we can tell, all of the AP activity in wild-type cells (WP551) reflects the 1-2% of APDelta 2-22 that is exported to the periplasm; no disulfide bonds form in APDelta 2-22 in the cytoplasm of wild-type cells. Thus, the increase in activity in the mutants is effectively relative to zero rather than to the activity seen in WP551.

We point out that all of these strains were grown in cysteine-containing medium (see Table II), since several of them required that amino acid for growth (see above) and we wished to grow all strains under the same conditions. The addition of cysteine, we discovered, resulted in some differences in results from those reported before (26). In particular, our previous study reported that combining the trxA mutation with the trxB mutation did not reduce the potency of the trxB mutation in allowing high levels of alkaline phosphatase activity. In the presence of cysteine, we now observe some effect of trxA on the trxB phenotype (Table II). However, during these studies, we also showed that removal of cysteine from the growth media restored the properties of the trxB trxA double mutant to those observed previously (data not shown).

Double mutants that lack either glutathione or glutathione reductase in combination with one of the proteins of the thioredoxin system allow a substantial amount of disulfide bond formation in the cytoplasm. Thus WP843 (trxA gor) and WP898 (trxA gshA) allow about as much APDelta 2-22 to form disulfide bonds as cells missing thioredoxin reductase (WP552) (Table II). Even more active APDelta 2-22 was found in the cytoplasm of WP759 (trxB gshA) and WP778 (trxB gor) when they were grown without DTT (Table III). We found that the rate of disulfide bond formation in APDelta 2-22 in these strains is faster than in cells missing only thioredoxin reductase (data not shown).

Since the cytoplasm of WP759 and WP778 appears to be a relatively oxidizing environment and these strains require DTT in the medium for high growth rates, we wondered whether other proteins also formed disulfide bonds efficiently in the cytoplasm of these strains. The serine protease domain of murein urokinase (Delta A-uPA) requires six disulfide bonds to fold into an active conformation (40). Like APDelta 2-22, when Delta A-uPA is expressed in the cytoplasm of wild-type cells, it cannot form its native disulfide bonds and, therefore, is not enzymatically active. It is also not active when it is expressed in a mutant missing thioredoxin reductase, even though APDelta 2-22 is active in the cytoplasm of this mutant. However, we showed previously that slight amounts of urokinase activity are observed when cells are allowed to sit on ice for several hours (26). The ability of Delta A-uPA to form disulfide bonds and hence become active in the cytoplasm of WP759 and WP778 was assessed by zymography with casein plasminogen agar underlays (Fig. 3). Substantially more active Delta A-uPA was found in WP759 and WP778 than in the cells lacking only thioredoxin reductase or wild-type cells. Thus, both APDelta 2-22 and Delta A-uPA form disulfide bonds more efficiently in the cytoplasm of WP759 and WP778 than in cells missing only thioredoxin reductase. Some of the active Delta A-uPA in these strains runs more slowly on the gel than native Delta A-uPA (Fig. 3). This material may be active Delta A-uPA that has formed disulfide bonds with other cytoplasmic proteins.

The Mutants Missing Components of the Thioredoxin or Glutaredoxin Systems Are Defective in Reducing Cytoplasmic Disulfide Bonds

We used a second approach to assess the ability of the mutants to reduce cytoplasmic disulfide bonds. Mutants with defects in disulfide reduction should be more sensitive to a thiol-specific oxidant than wild-type cells. The membrane-permeant thiol-specific oxidizing agent diamide (diazenedicarboxylic acid bis(N,N'-dimethylamide)) temporarily inhibits the growth of E. coli when it is added to mid-log phase cultures (41, 42). It has been assumed that this inhibition is due to the formation of disulfide bonds in the cytoplasm. Growth resumes after a period of time which is proportional to the amount of diamide added and is thought to be determined by the rate of disulfide bond reduction in the cytoplasm (43).

We determined the affect of diamide on the growth rate of some of the mutants (Fig. 4). In six of the seven strains tested, there is a good correlation between the length of diamide-induced growth inhibition and the ability of APDelta 2-22 to form disulfide bonds in the cytoplasm. Thus the mutants that allow APDelta 2-22 to form disulfide bonds in the cytoplasm also have a lower capacity to reduce cytoplasmic disulfide bonds generally. One exception to this pattern was the mutant AD494 (trxB), which did not display a very pronounced growth lag after diamide addition, but allowed a substantial amount of APDelta 2-22 to form disulfide bonds in the cytoplasm.


Fig. 4. Affect of diamide on the growth rate of mutants missing components of the thioredoxin and glutaredoxin systems. DHB4 (wild-type, black-triangle), AD494 (trxB, ×) WP840 (gor, bullet ), WP822 (trxA grxA grxC, square ), WP758 (gshA, black-square), WP843 (trxA gor, triangle ), and WP612 (trxA gshA, open circle ) were grown to an optical density at 600 nm of 0.2 in NZ-amide-A. Diamide was then added to a final concentration of 250 µM.
[View Larger Version of this Image (16K GIF file)]

SecB Has no Effect on the Ability of APDelta 2-22 to Fold in the Cytoplasm

As described above, the strains we constructed missing glutaredoxin 3 also lack SecB, since grxC::Cm is polar on secB. Since genes encoding proteins with unrelated functions are sometimes found in the same operon, we think it unlikely that there is any functional relationship between glutaredoxin 3 and SecB. However, SecB is likely to interact with APDelta 2-22 in the cytoplasm and has been found to slow the folding of the proteins it interacts with (27, 44). We wanted to rule out the possibility that the effects on AP activity we found in cells missing glutaredoxin 3 were due to the fact that they were also missing SecB. A mutant allele of secB (secB::Tn5) was introduced into WP551 (wild-type) and WP552 (trxB) by P1 transduction. Eliminating SecB in WP551 and WP552 had no affect of the amount of AP activity in these strains (data not shown). In addition, the expression level, stability, and rate of oxidation of APDelta 2-22 was unaffected by the absence of SecB (data not shown).


DISCUSSION

In this paper, we have investigated the role of the thioredoxin and glutaredoxin systems in determining the thiol-disulfide balance in the cytoplasm. This balance is too reducing for many protein disulfide bonds to form in the cytoplasm of wild-type cells. We have shown that eliminating certain combinations of the components of the thioredoxin and glutaredoxin systems by mutation results in high levels of disulfide bond formation. We demonstrated this alteration of the redox environment of the cytoplasm by assaying for disulfide bond formation in a cytoplasmic version of the normally periplasmic alkaline phosphatase, and by sensitivity of cells to the thiol-specific oxidant, diamide.

A Second Function for Thioredoxin Reductase

To better interpret our results, it is first necessary to summarize our evidence suggesting a second thioredoxin molecule in the E. coli cytoplasm. We previously showed that mutants lacking thioredoxin reductase (trxB) exhibited high levels of cytoplasmic AP activity due to efficient formation of disulfide bonds in the protein (26). This disulfide bond formation was not simply due to the absence of the reduced form of the known thioredoxin, since mutants lacking thioredoxin alone had little effect on AP activity. Furthermore, the properties of the trxB mutant could not be explained by its allowing the accumulation of oxidized thioredoxin, since the double mutant trxB trxA exhibited the same activity as the trxB mutant alone. These findings raised the possibility that the phenotype of trxB was due to a second function of the enzyme.

Results presented here strongly support that conclusion. Since trxA gor and trxA gshA mutants grow normally, while trxB gor and trxB gshA mutants are barely viable aerobically, it appears that thioredoxin reductase must be doing something in addition to its role in reducing the known thioredoxin. We suspect that our results are indicative of the existence of at least one additional thioredoxin in the E. coli cytoplasm for the following reasons. First, we expect that this second function of thioredoxin reductase must be such that it also contributes to the disulfide reducing environment of the cytoplasm. This expectation is based on the effects of the trxB mutants on disulfide bond formation in AP and on the finding that trxB gor and trxB gshA mutants require a disulfide reductant in the media to grow at a normal rate (Fig. 2). Second, thioredoxin reductase exhibits high substrate specificity for thioredoxins, and does not, for instance, act on glutaredoxins (16, 22).6 Consistent with these results, we have recently found two open reading frames in the E. coli chromosome that appear to correspond to new cytoplasmic thioredoxins. We are currently seeking mutants of these open reading frames to determine whether their properties fulfill predictions from the reasoning presented here.7,8 It should be noted that biochemical methods have failed to detect additional thioredoxins in E. coli.6

Which Are the Important Contributors to Maintaining Cysteines Residues in the Reduced State?

Those of our strains that are normally viable and that permit high levels of disulfide bond formation in AP are the trxB strain and the two double mutants, trxA gor and trxA gshA. We propose that, in the former strain, eliminating the reduction of the putative two thioredoxins is sufficient to dramatically increase disulfide bond formation in AP. With the latter two strains, while eliminating the known thioredoxin alone has little effect, combining the trxA mutation with mutations that totally inactivate the glutathione-glutaredoxin pathway does have a dramatic effect also. While this finding shows that it is not necessary to eliminate the function of the putative second thioredoxin to achieve high levels of disulfide bond formation, this molecule is probably still contributing to the thiol-disulfide redox environment, since the trxB gor and trxB gshA double mutants exhibit even higher disulfide bond formation than the three strains described above (Table III, Fig. 3). Thus, in the absence of any contribution from the two reductive pathways, disulfide bond formation is at its highest. Our results show that both the thioredoxin and glutaredoxin pathways contribute to keeping protein disulfide bonds reduced in the cytoplasm and that individual components of each pathway make some contribution to this redox activity.

Disulfide Bond Isomerization in the Cytoplasm?

We have assayed disulfide bond formation in the cytoplasm both by measuring the amount of active AP and, in some cases, by determining the amount of active urokinase. The latter protein requires the formation of six disulfide bonds for its activation. Elsewhere, we have shown that urokinase, when expressed in the E. coli periplasm is strongly dependent on DsbC, a known protein disulfide isomerase (46). This dependence is presumably due to the partial formation of incorrect disulfide bonds in urokinase. This finding raises the question of how formation of the proper disulfide bonds in urokinase can occur in the cytoplasm. It is not inconceivable that the cytoplasm also contains an isomerase. However, more likely is the explanation that the reducing environment of the cytoplasm in these mutants is sufficient to reduce disulfide bonds, particularly if the protein is not assembled into its most stable configuration. Thus, bonds may be reduced and reformed until the appropriate set of disulfide bonds has been assembled. Clearly, the cytoplasm of even the strongest mutant pairs we have examined must still contain disulfide reductants to maintain any cell viability (see discussion in next section).

Why Does E. coli Lacking Both the Thioredoxin and Glutaredoxin Pathways Grow so Poorly Aerobically?

One way to explain the poor aerobic growth of the trxB gor and trxB gshA strains is that an essential enzyme(s) is strongly dependent on the presence of at least one of the two reductive pathways, the glutaredoxin and thioredoxin systems. One candidate for such an enzyme is aerobic ribonucleotide reductase, which requires the reduction of a disulfide bond to complete its catalytic cycle and which, in vitro, can use thioredoxin or certain of the glutaredoxins for this purpose (16, 17). Since the anaerobic ribonucleotide reductase does not use the thioredoxin or glutaredoxin systems (47), the ability of these double mutants to grow well anaerobically would be predicted.

Alternatively, the trxB gor and trxB gshA mutants may grow poorly aerobically without a reductant because non-native disulfide bonds accumulate in a number of cytoplasmic proteins. Such "unwanted" disulfide bonds could affect the function and stability of cytoplasmic proteins, thus affecting cell physiology. However, our attempts to detect disulfide bonds in cytoplasmic proteins acquired in these strain backgrounds have yielded no indication that such bonds exist (data not shown). It may be that, in fact, many thiols of cytoplasmic proteins are buried and not available to form disulfide bonds (48).

Previous reports suggested that trxB gor and trxB gshA strains do not exhibit an aerobic growth defect, although the trxB gor strain described was not viable at 42 °C (38, 49). Suppressor mutations may have been unwittingly selected during the manipulations of these strains. We have shown that such suppressor mutations are quite common.

E. coli Likely Contains Other Protein Disulfide Reducing Pathways

In addition to our speculation that E. coli contains a second thioredoxin, the results with the strains constructed here indicate that there is likely to be a pathway or pathways in addition to the thioredoxin and glutaredoxin systems that can substitute for them. While the double mutants completely defective for both pathways grow very poorly aerobically, they do exhibit some growth. Furthermore, these poorly growing double mutants readily throw off suppressor mutations that allow rapid growth. These findings could be explained if there is, at least, one more lower activity system that maintains the thiol-disulfide balance in the cytoplasm and permits the slow growth of the double mutants. The suppressor mutations may increase the activity or the expression of such a system.

Further evidence that undiscovered disulfide reducing proteins are likely to exist in E. coli is provided by the fact that we have constructed a mutant lacking all three of the know reductants of the essential enzyme ribonucleotide reductase (thioredoxin, glutaredoxin 1, and glutaredoxin 3 (16, 17)). Thus, E. coli must contain at least one other protein that is capable of reducing ribonucleotide reductase in vivo.

Eliminating Some Components of the Thioredoxin and Glutaredoxin Systems Alters the Ability of Proteins to Form Disulfide Bonds in the Cytoplasm in Unexpected Ways

While it is clear that both the thioredoxin and glutaredoxin systems contribute to determining the thiol-disulfide balance in the cytoplasm, not all the differences in AP activity shown in Table II are explicable by a simple model. For instance, while cells missing glutaredoxin 3 allow some APDelta 2-22 to become oxidized in the cytoplasm, cells missing both glutaredoxin 3 and thioredoxin do not allow any oxidation of APDelta 2-22. However, it is known that mutations in certain genes of these pathways can alter the expression of the remaining components and thus change the thiol-disulfide balance in unexpected ways (45). Such compensatory responses to alteration of the redox balance might be expected to yield some confounding results in the assay for APDelta 2-22 activation.

Another unexpected finding is that cells missing thioredoxin reductase were only slightly more sensitive to diamide than wild-type cells, but allowed a substantial amount of APDelta 2-22 to form disulfides in the cytoplasm. Thus, there is probably some specificity in the disulfide bond reducing capability of the thioredoxin and glutaredoxin systems. The protein or proteins that are oxidized by diamide may be more susceptible to reduction by the glutaredoxin system than APDelta 2-22. Diamide preferentially oxidizes GSH to GSSG (10) and may raise the level of GSH-mixed disulfides. The finding that glutaredoxins show high activity with such substrates (25) may explain why mutants lacking thioredoxin reductase, but containing an active glutaredoxin system, are only slightly more sensitive to diamide than wild-type cells.


FOOTNOTES

*   This work was supported by a predoctoral fellowship from the National Eye Institute (to W. P.), a grant from the National Institute of General Medical Sciences, National Institutes of Health, and an American Cancer Society Research Professorship (to J. B.), and by grants from the Swedish Medical Research Council (B96-13Y-11213-02B) and the Swedish Cancer Society (961) (to A. H.)The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed.
1   F. Åslund, K. D. Berndt, and A. Holmgren, submitted for publication.
2   F. Åslund and A. Holmgren, unpublished results.
3   The abbreviations used are: PAPS, 3'-phosphoadenosine-5'-phosphosulfate; DTT, dithiothreitol; Km, kanamycin resistance; Cm, chloramphenicol resistance; Tc, tetracyclin resistance; AP, alkaline phosphatase.
4   F. Åslund, K. D. Berndt, G. Spyrou, and A. Holmgren, manuscript in preparation.
5   A. Vlamis-Gardikas and A. Holmgren, manuscript in preparation.
6   W. A. Prinz, F. Åslund, A. Holmgren, and J. Beckwith, unpublished results.
7   E. Stewart and J. Beckwith, unpublished results.
8   A. Jordan, F. Åslund, E. Pontis, P. Reichard, and A. Holmgren, submitted for publication.

ACKNOWLEDGEMENTS

We thank M. Russel and B. Demple for strains and C. Kumamoto for anti-SecB antiserum.


REFERENCES

  1. Doig, A. J., and Williams, D. H. (1991) J. Mol. Biol. 217, 389-398 [Medline] [Order article via Infotrieve]
  2. Creighton, T. E. (1992) Protein Folding, W. H. Freeman and Co., New York
  3. Schultz, G. E., and Schirmer, R. H. (1979) Principles of Protein Structure, Springer-Verlag, New York
  4. Thornton, J. M. (1981) J. Mol. Biol. 151, 261-287 [Medline] [Order article via Infotrieve]
  5. Ziegler, D. M., and Poulsen, L. L. (1977) Trends Biochem. Sci. 2, 79-81
  6. Gilbert, H. F. (1990) Adv. Enzymol. Relat. Areas Mol. Biol. 63, 69-172 [Medline] [Order article via Infotrieve]
  7. Pollitt, S., and Zalkin, H. (1983) J. Bacteriol. 153, 27-32 [Medline] [Order article via Infotrieve]
  8. Derman, A. I., and Beckwith, J. (1991) J. Bacteriol. 173, 7719-7723 [Medline] [Order article via Infotrieve]
  9. Nilsson, B., Berman-Marks, C., Kuntz, I. D., and Anderson, S. (1991) J. Biol. Chem. 266, 2970-2977 [Abstract/Free Full Text]
  10. Kosower, N. S., and Kosower, E. M. (1978) Int. Rev. Cytol. 54, 109-160 [Medline] [Order article via Infotrieve]
  11. Hwang, C., Sinsky, A. J., and Lodish, H. F. (1992) Science 257, 1496-1502 [Medline] [Order article via Infotrieve]
  12. Saxena, V. P., and Wetlaufer, D. B. (1970) Biochemistry 9, 5015-5023 [Medline] [Order article via Infotrieve]
  13. Lyles, M. M., and Gilbert, H. F. (1991) Biochemistry 30, 613-619 [Medline] [Order article via Infotrieve]
  14. Walker, K. W., and Gilbert, H. F. (1994) J. Biol. Chem. 269, 28487-28493 [Abstract/Free Full Text]
  15. Holmgren, A. (1985) Annu. Rev. Biochem. 54, 237-271 [CrossRef][Medline] [Order article via Infotrieve]
  16. Holmgren, A. (1989) J. Biol. Chem. 264, 13963-13966 [Free Full Text]
  17. Åslund, F., Ehn, B., Miranda-Vizuete, A., Pueyo, C., and Holmgren, A. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 9813-9817 [Abstract/Free Full Text]
  18. Martin, J. L. (1995) Structure 3, 245-250 [Medline] [Order article via Infotrieve]
  19. Krause, G., Lundström, J., Barea, J. L., Pueyo de la Cuesta, C., and Holmgren, A. (1991) J. Biol. Chem. 266, 9494-9500 [Abstract/Free Full Text]
  20. Holmgren, A. (1984) Methods Enzymol. 107, 295-300 [Medline] [Order article via Infotrieve]
  21. Åslund, F., Nordstrand, K., Berndt, K. D., Nikkola, M., Bergman, T., Ponstingl, H., Jörnvall, H., Otting, G., and Holmgren, A. (1996) J. Biol. Chem. 271, 6736-6745 [Abstract/Free Full Text]
  22. Holmgren, A. (1979) J. Biol. Chem. 254, 9113-9119 [Medline] [Order article via Infotrieve]
  23. Gleason, F. K., and Holmgren, A. (1988) FEMS Microbiol. Rev. 54, 271-298
  24. Holmgren, A., and Björnstedt, M. (1995) Methods Enzymol. 252, 199-208 [CrossRef][Medline] [Order article via Infotrieve]
  25. Holmgren, A., and Åslund, F. (1995) Methods Enzymol. 252, 283-292 [Medline] [Order article via Infotrieve]
  26. Derman, A. I., Prinz, W. A., Belin, D., and Beckwith, J. (1993) Science 262, 1744-1747 [Medline] [Order article via Infotrieve]
  27. Derman, A. I., Puziss, J. W., Bassford, P. J., Jr., and Beckwith, J. (1993) EMBO J. 12, 879-888 [Abstract]
  28. Miller, J. H. (1992) A Short Course in Bacterial Genetics, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  29. Russel, M., and Model, P. (1986) in Thioredoxin and Glutaredoxin Systems: Structure and Function (Holmgren, A., Brändén, C. I., Jörnvall, H., and Sjöberg, B.-M., eds), pp. 331-337, Raven Press, New York
  30. Russel, M., and Model, P. (1986) J. Biol Chem. 261, 14997-15005 [Abstract/Free Full Text]
  31. Greenberg, J. T., and Demple, B. (1986) J. Bacteriol. 168, 1026-1029 [Medline] [Order article via Infotrieve]
  32. Russel, M., and Holmgren, A. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 990-994 [Abstract]
  33. Russel, C. B., Thaler, D. S., and Dahlquist, F. W. (1989) J. Bacteriol. 171, 2609-2613 [Medline] [Order article via Infotrieve]
  34. Fellay, R., Frey, J., and Krisch, H. (1987) Gene (Amst.) 52, 147-154 [CrossRef][Medline] [Order article via Infotrieve]
  35. Kim, E. E., and Wyckoff, H. W. (1989) Clin. Chim. Acta 186, 175-188
  36. Michaelis, S., Inouye, H., Oliver, D., and Beckwith, J. (1983) J. Bacteriol. 154, 366-374 [Medline] [Order article via Infotrieve]
  37. Miranda-Vizuete, A., Martinez-Galisteo, E., Åslund, F., Lopez-Barea, J., Pueyo, C., and Holmgren, A. (1994) J. Biol. Chem. 269, 16631-16637 [Abstract/Free Full Text]
  38. Kren, B., Parsell, D., and Fuchs, J. A. (1988) J. Bacteriol. 170, 308-315 [Medline] [Order article via Infotrieve]
  39. Russel, M., Model, P., and Holmgren, A. (1990) J. Bacteriol. 172, 1923-1929 [Medline] [Order article via Infotrieve]
  40. Neurath, H. (1984) Science 204, 350-357
  41. Wax, R., Rosenberg, E., Kosower, N. S., and Kosower, E. M. (1970) J. Bacteriol. 101, 1092-1093 [Medline] [Order article via Infotrieve]
  42. Kosower, N. S., and Kosower, E. M. (1995) Methods Enzymol. 251, 123-133 [Medline] [Order article via Infotrieve]
  43. Hibberd, K. A., Berget, P. E., Warner, H. R., and Fuchs, J. A. (1978) J. Bacteriol. 133, 1150-1155 [Medline] [Order article via Infotrieve]
  44. Randall, L. L., and Hardy, S. J. (1995) Trends Biochem. Sci. 20, 65-69 [CrossRef][Medline] [Order article via Infotrieve]
  45. Miranda-Vizuete, A., Rodríguez-Ariza, A., Toribio, F., Holmgren, A., López-Barea, J., and Pueyo, C. (1996) J. Biol. Chem. 271, 19099-19103 [Abstract/Free Full Text]
  46. Rietsch, A., Belin, D., Martin, N., and Beckwith, J. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13048-13053 [Abstract/Free Full Text]
  47. Mulliez, E., Ollagnier, S., Fontecave, M., Eliasson, R., and Reichard, P. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8759-8762 [Abstract]
  48. Chang, Y.-Y., and Cronan, J. E., Jr. (1995) J. Biol. Chem. 270, 7896-7901 [Abstract/Free Full Text]
  49. Tuggle, C. K., and Fuchs, J. A. (1985) J. Bacteriol. 162, 448-450 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.